Xian-De Liu

4PUBLICATIONS
44CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 01, 2023
SETD2 Loss and ATR Inhibition Synergize to Promote cGAS Signaling and Immunotherapy Response in Renal Cell Carcinoma.

Xian-De Liu, Yan-Ting Zhang, Daniel J McGrail

|Jun 27, 2020
Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney Cancer.

Sophie J Cowman, Daniel G Fuja, Xian-De Liu

|May 03, 2020
PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma.

Xian-De Liu, Wen Kong, Christine B Peterson

|Jul 21, 2018
VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma.

Jing Zhang, Tao Wu, Jeremy Simon

Pageof 1